@article{ref1,
title="Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine",
journal="European Neuropsychopharmacology",
year="1994",
author="Möller, H. J. and Steinmeyer, E. M.",
volume="4",
number="1",
pages="55-59",
abstract="There is some empirical evidence that selective serotonin reuptake inhibitors reduce suicidal ideas faster than other antidepressants. These findings are well in line with the theory of a serotonergic hypofunction in suicidal patients. To test this hypothesis the data of a 6-week double-blind control-group study comparing paroxetine versus amitriptyline were analyzed with respect to suicidality. The global antidepressive efficacy was comparable under dosages of 30 mg paroxetine or 150 mg amitriptyline per day. A differentiated analysis failed to confirm the hypothesis of a faster reduction of suicidal cognitions by paroxetine.<p /><p>Language: en</p>",
language="en",
issn="0924-977X",
doi="10.1016/0924-977x(94)90315-8",
url="http://dx.doi.org/10.1016/0924-977x(94)90315-8"
}